H. Aupperle

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Myxomatous Degeneration of the Canine Mitral Valve: From Gross Changes to Molecular Events

Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine

Insights into Serotonin Signaling Mechanisms Associated with Canine Degenerative Mitral Valve Disease

Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation

TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves

Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone—a pilot study

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration

Hemotrophic Mycoplasmas Induce Programmed Cell Death in Red Blood Cells

Pathology of myxomatous mitral valve disease in the dog

Functional role of estrogen in pituitary tumor pathogenesis

Cardiac troponin I and C-reactive protein concentrations in dogs with severe pulmonic stenosis before and after balloon valvuloplasty

Biomarkers in cardiovascular disease: Beyond natriuretic peptides

Pulmonary thromboembolism

Age Sensitivity of NFκB Abundance and Programmed Cell Death in Erythrocytes Induced by NFκB Inhibitors

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs

Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease

Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model

Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity

Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic

Acute and Long-Term Effects of Full-Power Electroporation Ablation Directly on the Porcine Esophagus

Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Growth Factors, Matrices, and Forces Combine and Control Stem Cells

Cyclical endometrial steroid hormone receptor expression and proliferation intensity in the mare

Ablation of atrial fibrillation and esophageal injury: Effects of energy source and ablation technique

Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus

Pathology, protein expression and signaling in myxomatous mitral valve degeneration: Comparison of dogs and humans

Effects of autologous bone marrow stem cell transplantation on beta-adrenoceptor density and electrical activation pattern in a rabbit model of non-ischemic heart failure

An immunohistochemical study of the role of matrix metalloproteinases and their tissue inhibitors in chronic mitral valvular disease (valvular endocardiosis) in dogs

Expression of Transforming Growth Factor-β1, -β2 and -β3 in Normal and Diseased Canine Mitral Valves

Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease

MSG1, a surface-localised protein of Mycoplasma suis is involved in the adhesion to erythrocytes

Expression of Genes Encoding Matrix Metalloproteinases (MMPs) and their Tissue Inhibitors (TIMPs) in Normal and Diseased Canine Mitral Valves

Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease

Histomorphological findings and expression of matrix metalloproteinases and their tissue specific inhibitors (TIMPs) in normal tricuspid valves and in chronic tricuspid valvular disease in dogs

Immunohistochemical characterization of the extracellular matrix in normal mitral valves and in chronic valve disease (endocardiosis) in dogs